Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.
J Bras Nefrol
; 42(2 suppl 1): 47-48, 2020 Aug 26.
Article
in English, Portuguese
| MEDLINE | ID: covidwho-740467
ABSTRACT
This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Angiotensin-Converting Enzyme Inhibitors
/
Coronavirus Infections
/
Angiotensin II Type 1 Receptor Blockers
/
Betacoronavirus
/
Hypertension
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
/
Portuguese
Journal:
J Bras Nefrol
Journal subject:
Nephrology
Year:
2020
Document Type:
Article
Affiliation country:
2175-8239-JBN-2020-S112
Similar
MEDLINE
...
LILACS
LIS